.

Pharmaceutical Business Intelligence

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

ORPHENADRINE CITRATE Drug Profile

« Back to Dashboard

Which patents cover Orphenadrine Citrate, and what substitute generic drugs are available?

Orphenadrine Citrate is a drug marketed by Watson Labs, Sandoz, Tedor Pharma Inc, Invagen Pharms, West-ward Pharms Int, Ascot, Impax Pharms, Akorn, Gavis Pharms, Sagent Pharms, and Stevens J. and is included in fifteen NDAs.

The generic ingredient in ORPHENADRINE CITRATE is aspirin; caffeine; orphenadrine citrate. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.

Summary for Tradename: ORPHENADRINE CITRATE

Patents:0
Applicants:11
NDAs:15
Suppliers / Packagers: see list29
Clinical Trials: see list228
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ORPHENADRINE CITRATE at DailyMed

Pharmacology for Tradename: ORPHENADRINE CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL084303-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
ORPHENADRINE CITRATE
orphenadrine citrate
INJECTABLE;INJECTION040463-001Mar 4, 2003RXNoNo► Subscribe► Subscribe
Tedor Pharma Inc
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL040249-001Jan 29, 1999RXNoNo► Subscribe► Subscribe
Gavis Pharms
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL040284-001Jun 19, 1998RXNoNo► Subscribe► Subscribe
Ascot
ORPHENADRINE CITRATE
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL088067-001Apr 6, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc